2nd December 2024 by Dr Louise Hudman
This is new NICE guidance on a medication called ‘Vibegron’. It was published in Sep 24.
Vibegron is a bladder muscle relaxant. It helps to treat symptoms of overactive bladder syndrome. It is a beta-3 adrenergic receptor agonist. Mirabegron is also a beta-3 adrenergic receptor agonist.
When can it be used?
Clinical psychologists to give GP talk on ADHD and autism outcomes
NASGP members are invited to a new talk, 'Better outcomes for patients with ADHD and autism', by Dr Alesia Moulton-Perkins and Dr Jessie Gough.
Tirzepatide for managing overweight and obesity
This is guidance from NICE on tirzepatide (Mounjaro) in overweight and obesity was first published in December 2024.
Immunotherapy (Acarizax) for dust mite allergy and allergic rhinitis
NICE has approved the use of a new immunotherapy for treating house dust mite-related allergic rhinitis.
"The NASGP and the GP locum chambers that I'm in have provided invaluable assistance both before and through Covid-19 to me as a full-time GP locum. All aspects of locum work have been made easier as a result of membership and the chamber's support structure - from accessing work, to ensuring invoicing and documentation is all sorted, and access to other locums as peer support. Having a chamber manager means I feel more secure and can devote more of my energy on my clinical work."
Dr Richard Smith, GP, Suffolk
